Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Primary biliary cholangitis (PBC) has been regarded as female-predominant without evidence of gender difference in survival. We aimed to compare the overall survival, incidence and prevalence of PBC in two well defined population-based studies over a recent decade, considering also sex ratios and mortality. We have taken advantage of population-wide records, during 2000–2009, in Lombardia, Northern Italy and Denmark. We focused on the incident cases of PBC, including gender and outcome, among 9.7 million inhabitants of Lombardia and 5.5 million of Denmark. In Lombardia there were 2,970 PBC cases with a female:male ratio of 2.3:1. The age/sex-adjusted annual incidence of PBC was 16.7 per million. Point prevalence was 160 per million on January 1 st 2009. In Denmark there were 722 cases of incident PBC, female:male ratio was 4.2:1 and the annual incidence was 11.4 per million, a point prevalence of 115 per million in 2009. Cox regression multivariate analysis identified male sex as an independent predictor of all-cause mortality in both Italian (HR 2.36) and Danish population (HR 3.04). Our data indicate for PBC a sex ratio significantly lower than previously cited, a reversal of the usual latitudinal difference in prevalence and a surprisingly higher overall mortality for male patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“although some recent data suggest an increasing male prevalence [18]; the female predominance of PBC continues to be unexplained [19].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The disease is female predominant (as confirmed by large registry efforts)”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD
Ahmad, O. B., Boschi-Pinto, C., López, A. D., Murray, C. J. L., Lozano, R., & Inoue, M. (2000) · Cited by 1,957
The Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
Sex differences in autoimmune disease
Whitacre, C. C. (2001) · Nature Immunology · doi:10.1038/ni0901-777 · Cited by 1,271
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Self-citationWhen an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 864
(2015) · Diagnostic Imaging: Gastrointestinal · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 811
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
“Whether sex can be used as an independent prognostic factor to determine PBC outcome, however, remains to be shown [65,18].”
Self-citationLleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationRecent advances in clinical practice: Epidemiology of autoimmune liver diseases
Trivedi, P. J., & Hirschfield, G. M. (2021) · Gut · doi:10.1136/gutjnl-2020-322362 · Cited by 244
Lv, T., Chen, S., Li, M., Zhang, D., Kong, Y., & Jia, J. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15329 · Cited by 165
Current understanding of primary biliary cholangitis
Tanaka, A. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0028 · Cited by 158
“1:1.(19) The reason for the relative increase in the number of male patients with PBC remains unclear, but a better recognition and a true increase in the incidence of PBC are likely responsible.”
BackgroundPrimary biliary cholangitis: Epidemiology, prognosis, and treatment
Trivella, J., John, B. V., & Levy, C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000179 · Cited by 159
“[23] Modern literature has demonstrated that, although PBC remains a female-predominant disease, it is also more prevalent in males than previously thought, with a female-to-male ratio closer to 4–6:1.[24,25] PBC in males is often diagnosed at an older age, once the disease is more advanced.”
BackgroundIncreasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment
Lü, M., Zhou, Y., Haller, I. V., Romanelli, R. J., VanWormer, J. J., Rodriguez, C. V., Anderson, H., Boscarino, J. A., Schmidt, M. A., Daida, Y. G., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.12.033 · Cited by 151
“Although there are few studies of PBC trends in the United States, studies from Europe and Asia reported a generally steady to slightly increasing PBC prevalence in the past decade, with roughly 4 to 9 times higher prevalence among women compared with men.(2,3) However, because these studies used data drawn from natio…”
MethodResultInfluentialPrimary biliary cholangitis: a comprehensive overview
Lleò, A., Marzorati, S., Anaya, J., & Gershwin, M. E. (2017) · Hepatology International · doi:10.1007/s12072-017-9830-1 · Cited by 119
“In selected cases, Table 1 Selected studies of prevalence, incidence, and sex ratio in primary biliary cholangitis Modified from [12]”
BackgroundSelf-citationTanaka, A., Mori, M., Matsumoto, K., Ohira, H., Tazuma, S., & Takikawa, H. (2019) · Hepatology Research · doi:10.1111/hepr.13342 · Cited by 108
Pathogen infections and primary biliary cholangitis
Tanaka, A., Leung, P. S. C., & Gershwin, M. E. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13198 · Cited by 96
Self-citationCheung, A., Lammers, W. J., Perez, C. F. M., van Buuren, H. R., Gulamhusein, A. F., Trivedi, P. J., Lazaridis, K. N., Ponsioen, C. Y., Floreani, A., Hirschfield, G. M., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.028 · Cited by 90
Self-citationLü, M., Li, J., Haller, I. V., Romanelli, R. J., VanWormer, J. J., Rodriguez, C. V., Raebel, M. A., Boscarino, J. A., Schmidt, M. A., Daida, Y. G., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.10.018 · Cited by 93
John, B. V., Aitcheson, G. A., Schwartz, K. B., Khakoo, N. S., Dahman, B. A., Deng, Y., Goldberg, D. S., Martin, P. B., Taddei, T. H., Levy, C., et al. (2021) · Hepatology · doi:10.1002/hep.31776 · Cited by 70
“01; P value unavailable).(7) Data from the United States by Sayiner et al.”
BackgroundTwenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists
Webb, G. J., Rana, A. A., Hodson, J. A., Akhtar, M. Z., Ferguson, J., Neuberger, J., Vierling, J. M., & Hirschfield, G. M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.09.062 · Cited by 63
Marschall, H.-U., Henriksson, I., Lindberg, S., Söderdahl, F., Thuresson, M., Wahlin, S., & Ludvigsson, J. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-47890-2 · Cited by 60
Selmi, C. F., & Gershwin, M. E. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-017-0074-2 · Cited by 63
“a These inclusion criteria are applicable to any patient with at least one symptom of ocular or oral dryness, defined as a positive response to at least one of the following questions [1]: Have you had daily, persistent, troublesome dry eyes for more than 3 months [2]? Do you have a recurrent sensation of sand or grav…”
Self-citationPrimary biliary cholangitis: A tale of epigenetically-induced secretory failure?
Rodrigues, P. M., Perugorria, M. J., Santos-Laso, A., Bujanda, L., Beuers, U., & Banales, J. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.020 · Cited by 57
The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?
Henze, L., Schwinge, D., & Schramm, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01567 · Cited by 63
“PBC is a rare AID of the liver with a female to male ratio as high as 9:1 and characterized by the presence of anti-mitochondrial antibodies (AMAs), specific antinuclear antibodies (ANAs), and strong HLA associations (98, 121, 122).”
BackgroundGaloosian, A., Hanlon, C. L., Zhang, J., Holt, E. W., & Yimam, K. K. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2019.00049 · Cited by 76
“PBC frequently develops around the ages of 40–60 years, with women more commonly affected than men (at a ratio of 9:1).(4,11,30) This femaleto-male ratio also persists in other countries, such as Taipei (9:1), Japan (9.”
BackgroundSex-related factors in autoimmune liver diseases
Schwinge, D., & Schramm, C. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0715-8 · Cited by 66
Harms, M. H., Janssen, Q. P., Adam, R. A., Duvoux, C., Mirza, D. F., Hidalgo, E. L., Watson, C. J. E., Wigmore, S. J., Pinzani, M., Isoniemi, H., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15060 · Cited by 58
“Missing values: Barcelona criteria: 48 (47%), Paris I criteria: 37 (36%), GLOBE criteria: 45 (44%). epidemiological studies could contribute to these findings, as well as data that suggest males are less likely to respond well to treatment with UDCA.30,31 The MELD score at time of transplantation was slightly but sign…”
ResultGazda, J., Dražilová, S., Janíčko, M., & Jarčuška, P. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/9151525 · Cited by 61
The liver as a central "hub" of the immune system: pathophysiological implications
Ronca, V., Gerussi, A., Collins, P., Parente, A., Oo, Y. H., & Invernizzi, P. (2025) · Physiological Reviews · doi:10.1152/physrev.00004.2023 · Cited by 59
Self-citationKennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Eric Gershwin, M., Bernuzzi, F., Franchitto, A., Alvaro, D., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802606r · Cited by 47
“Recent studies have indicated that the incidence and prevalence of PBC are rising (2, 3).”
BackgroundSelf-citationHao, J., Yang, T., Zhou, Y., Gao, G.-Y., Xing, F., Peng, Y., Tao, Y., & Liu, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00944-9 · Cited by 47
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database
Marzioni, M., Bassanelli, C., Ripellino, C., Urbinati, D., & Alvaro, D. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.11.008 · Cited by 49
Rheumatic Manifestations in Autoimmune Liver Disease
Selmi, C. F., Generali, E., & Gershwin, M. E. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.09.008 · Cited by 50
Self-citationImmunologic characterization of Ewing's sarcoma using mesenchymal and neural markers.
Lizard‐Nacol, S., Lizard, G., Justrabo, E., & Turc‐Carel, C. (1989) · Europe PMC (PubMed Central) · Cited by 55
Contemporary epidemiology of primary biliary cholangitis
Colapietro, F., Bertazzoni, A., & Lleo, A. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.001 · Cited by 43
Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases
Zhang, W., Mackay, C. R., & Gershwin, M. E. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300016 · Cited by 47
Self-citationE. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yang, Y., Choi, J., Chen, Y., Invernizzi, P., Yang, G., Zhang, W., Shao, T., Jordan, F., Nemeria, N. S., Coppel, R. L., et al. (2022) · Hepatology · doi:10.1002/hep.32172 · Cited by 44
“In light of recent reports of increasing prevalence of PBC in men,[55,56] westernization of culture along with improvements in hygiene might account for a changed frequency of UTI and slight change in gender bias in PBC.”
BackgroundSelf-citationThe immunobiology of female predominance in primary biliary cholangitis
Gerussi, A., Cristoferi, L., Carbone, M., Asselta, R., & Invernizzi, P. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.015 · Cited by 41
Self-citationA Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.
Onofrio, F. Q., Hirschfield, G. M., & Gulamhusein, A. F. (2019) · Europe PMC (PubMed Central) · Cited by 58
Hepatic immune regulation and sex disparities
Burra, P., Zanetto, A., Schnabl, B., Reiberger, T., Montaño‐Loza, A. J., Asselta, R., Karlsen, T. H., & Tacke, F. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00974-5 · Cited by 45
“94,95).”
Primary Biliary Cholangitis: advances in management and treatment of the disease
Invernizzi, P., Floreani, A., Carbone, M., Marzioni, M., Craxì, A., Muratori, L., Gentilucci, U. V., Gardini, I., Gasbarrini, A., Kruger, P., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.05.001 · Cited by 48
“(2016) [6] are consistent with what has been reported by Orphanet (12,740 prevalent cases applying the 2.”
BackgroundResultInfluentialSelf-citationReview article: pathophysiology and management of primary biliary cholangitis
Leung, K. K., Deeb, M., & Hirschfield, G. M. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16023 · Cited by 40
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice
Invernizzi, F., Cilla, M., Trapani, S., Guarino, M., Cossiga, V., Gambato, M., Morelli, M. C., Morisco, F., Burra, P., & Floreani, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060925 · Cited by 45
“[74] demonstrated that male sex was associated to an increased risk of all-cause mortality.”
BackgroundSex-Dependent Differences in Cholestasis
Ismail, A., Kennedy, L. L., & Francis, H. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.06.010 · Cited by 39
“Male subjects with PBC likely have a higher overall mortality rate due to unclear etiology, potential underdiagnosis, and a more underlying pathophysiological process.(5,7,8) PSC similarly has a sex predisposition, with male subjects being more commonly affected (up to 60%), and an average age of diagnosis close to 40…”
BackgroundSebode, M., Kloppenburg, A. G., Aigner, A., Lohse, A. W., Schramm, C., & Linder, R. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1135-9306 · Cited by 35
The Genetics and Epigenetics of Primary Biliary Cholangitis
Tanaka, A., Leung, P. S. C., & Gershwin, M. E. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.03.002 · Cited by 36
Self-citationNew Therapies on the Horizon for Primary Biliary Cholangitis
Tanaka, A. (2023) · Drugs · doi:10.1007/s40265-023-01979-1 · Cited by 33
“Although PBC usually affects middle-aged women, recent epidemiological studies have indicated a decrease in the female-to-male ratio owing to the increasing number of male patients [2, 3].”
Recent advances in the diagnosis and treatment of primary biliary cholangitis
Huang, Y.-Q. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i33.1419 · Cited by 31
The genetics of primary biliary cholangitis
Tanaka, A., Leung, P. S. C., & Gershwin, M. E. (2018) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000507 · Cited by 30
Self-citationMechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?
Yang, Y., He, X.-S., Rojas, M., Leung, P. S. C., & Gao, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1184252 · Cited by 32
Shen, N., Pan, J., Miao, H., Zhang, H., Xing, L., & Yu, X. F. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1304 · Cited by 30
Fan, X., Wang, T., Shen, Y., Xi, X., & Yang, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-06807-7 · Cited by 35
Floreani, A., Gabbia, D., & Martin, S. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042194 · Cited by 29
“These complications are more aggressive and have a worse prognosis in males than in females [3].”
BackgroundPrimary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use
Sayıner, M., Golabi, P., Stepanova, M., Younossi, I. M., Nader, F., Racila, A., & Younossi, Z. M. (2018) · Hepatology · doi:10.1002/hep.30174 · Cited by 27
“(7) This prevalence rate appears to vary geographically, and rates are reported to be higher in northern European countries, United Kingdom, and Scandinavian countries.(8-12) Furthermore, PBC is more common among patients with a first-degree relative with the disease, reflecting a possible genetic susceptibility.”
BackgroundChanges in the Epidemiology of Primary Biliary Cholangitis
Lleò, A., & Colapietro, F. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.03.001 · Cited by 28
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis
Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13181580 · Cited by 31
“90% of patients are female), the positivity to disease-specific anti-mitochondrial autoantibodies (AMAs), the prototypical liver histopathology and frequent concomitance with other autoimmune diseases (e.g., Hashimoto’s thyroiditis, rheumatoid arthritis) [5,6].”
BackgroundEpidemiological and economical burden of cholestatic liver disease
Mol, B., Werner, E., Culver, E. L., van der Meer, A. J., Bogaards, J. A., & Ponsioen, C. Y. (2025) · Hepatology · doi:10.1097/hep.0000000000001341 · Cited by 31
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
Abenavoli, L., Procopio, A. C., Fagoonee, S., Pellicano, R., Carbone, M., Luzza, F., & Invernizzi, P. (2020) · Diseases · doi:10.3390/diseases8020020 · Cited by 26
Self-citationCao, H., Zhu, B., Qu, Y., & Zhang, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02815 · Cited by 25
“Women are more susceptible to suffering this disease than men, although some recent data suggest an increasing male prevalence (2).”
ResultWilde, A. B., Lieb, C., Leicht, E., Greverath, L. M., Steinhagen, L. M., de Chamorro, N. W., Petersen, J., Hofmann, W. P., Hinrichsen, H. M., Heyne, R., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051061 · Cited by 24
“An increasing proportion of male patients, as postulated in a recent epidemiological study [15] and a recent German retrospective study [11], was not observed in the present cohort.”
Chen, S., Duan, W., Li, M., Li, S., Lv, T., Tian, Q., Wang, Q., Wu, X., Zhao, X., Wang, X., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14521 · Cited by 25
John, B. V., Dahman, B. A., Deng, Y., Khakoo, N. S., Taddei, T. H., Kaplan, D. E., & Levy, C. (2021) · Liver International · doi:10.1111/liv.15079 · Cited by 28
Tanaka, A., Kono, H., Leung, P. S. C., & Gershwin, M. E. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.104021 · Cited by 24
Self-citationGender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA
Adejumo, A., Akhtar, D. H., Dennis, B. B., Cholankeril, G. T., Alayo, Q. A., Ogundipe, O. A., Kim, D., & Ahmed, A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06402-3 · Cited by 26
“1 3 UDCA, and higher PBC mortality [22], our study showed comparable gender outcomes, except for higher charges in males.”
ResultGeoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland
Beretta‐Piccoli, B. T., Stirnimann, G., Cerny, A., Semela, D., Hessler, R., Helbling, B., Stickel, F., Bakker, C. A. J. K.-D., Bihl, F. K., Giostra, E., et al. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8656-x · Cited by 22
Self-citationGeoepidemiology and changing mortality in primary biliary cholangitis
Floreani, A., Tanaka, A., Bowlus, C. L., & Gershwin, M. E. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1333-2 · Cited by 21
Self-citationAging-Related Molecular Pathways in Chronic Cholestatic Conditions
Pinto, C., Ninfole, E., Benedetti, A., Maroni, L., & Marzioni, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00332 · Cited by 18
“PBC is an autoimmune liver disease that predominantly affects women [maybe due to the observation that 48% of PBC patients experienced prior recurrent urinary tract infections, more frequent in women and caused by Escherichia coli (77)], characterized by mainly portal inflammation, chronic cholestasis and destruction…”
BackgroundSex differences in clinical presentation and prognosis in patients with primary biliary cholangitis
Abdulkarim, M., Zenouzi, R., Sebode, M., Schulz, L., Quaas, A., Lohse, A. W., Schramm, C., & Weiler‐Normann, C. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1683226 · Cited by 22
“Of note, recent reports suggested that PBC may be more frequent in men than previously thought [15,23].”
BackgroundPost-Transplant Immunosuppression in Autoimmune Liver Disease
Kelly, C., Zen, Y., & Heneghan, M. A. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.07.002 · Cited by 18
Primary Biliary Cholangitis in Males
Shaker, M., Mansour, N., & John, B. V. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.008 · Cited by 21
Levy, C., Buchanan-Peart, K.-A., MacEwan, J. P., Levine, A., Nair, R., Wheeler, D., Bessonova, L., Goel, A., Gish, R. G., & Bonder, A. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000677 · Cited by 25
Xu, Y., Zhao, Z., Yan, E. P., Lian, Z., & Zhang, W. (2023) · Medicine Advances · doi:10.1002/med4.23 · Cited by 19
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives
Villani, R., Serviddio, G., Avolio, C., Cassano, T., & D’Amico, E. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01128-8 · Cited by 17
“The incidence is generally between 1 and 2 per 100,000 population per year and the disease is female predominant [104, 105].”
BackgroundWatt, M., Hyde, A. M., Johnson, E., Wright, G. M., Well, S. V., Sadasivan, C., Lee‐Baggley, D., Spence, J. C., Mason, A. L., Ko, H. H., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000316 · Cited by 16
“This is not unexpected, given that the female: male ratio of patients with PBC is estimated to be as high as 10:1, [47] and other studies evaluating mind-body interventions have reported a higher prevalence of female participants.”
BackgroundGaloosian, A., Hanlon, C. L., Tana, M. M.-S., Cheung, R. C., & Wong, R. J. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05809-x · Cited by 18
Rigamonti, C., Cittone, M. G., Manfredi, G. F., De Benedittis, C., Paggi, N., Baorda, F., Di Benedetto, D., Minisini, R., & Pirisi, M. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100952 · Cited by 15
“Primary biliary cholangitis (PBC) is a chronic autoimmune chol-angiopathy 1 that predominantly affects women, 2,3 leading to immune-mediated damage to biliary ducts.”
BackgroundRisk stratification and prognostic modelling in primary biliary cholangitis
Goet, J. C., Harms, M. H., Carbone, M., & Hansen, B. E. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.006 · Cited by 19
Self-citationA National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis
Manno, V., Gerussi, A., Carbone, M., Minelli, G., Taruscio, D., Conti, S., & Invernizzi, P. (2019) · Hepatology Communications · doi:10.1002/hep4.1407 · Cited by 15
“(11) Lower F:M ratios have also been reported by recent studies based on administrative databases.(5,6,8) The burden of comorbidities in terms of clinical and prognostic impact and costs for the health services is of key importance in medicine.”
BackgroundResultInfluentialSelf-citationGentilucci, U. V., Rosina, F., Pace-Palitti, V., Sacco, R., Pellicelli, A. M., Chessa, L., Vincentis, A. D., Barlattani, M., Barlattani, A., Feletti, V., et al. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1669702 · Cited by 17
“2:1 [19,20], suggesting a muted difference in the frequency of PBC between the sexes.”
BackgroundCarbone, M., Gerussi, A., Cardinale, V., Cazzagon, N., Cossiga, V., Lleò, A., Marrone, G., Marzioni, M., Moschetta, A., Muratori, L., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.002 · Cited by 18
Self-citationImproving prognosis in primary biliary cholangitis – Therapeutic options and strategy
Harms, M. H., van Buuren, H. R., & van der Meer, A. J. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.004 · Cited by 18
Kimura, N., Takamura, M., Takeda, N., Watanabe, Y., Arao, Y., Takatsuna, M., Takeuchi, S., Abé, H., Setsu, T., Kamimura, H., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10163-0 · Cited by 16
“The disease is predominant in females; however, recent studies have shown an increase in its prevalence in males [1].”
ResultPrimary biliary cholangitis: primary autoimmune disease or primary secretory defect
Floreani, A., Gabbia, D., & Martin, S. D. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2242771 · Cited by 16
“It involves predominantly females, with a female/male ratio of 9:1 [2], although recent observations indicate an F/M ratio lower than previously reported [3].”
ResultGeoepidemiology and (epi-)genetics in primary biliary cholangitis
Roberto, R., Laura, C., Tanaka, A., & Invernizzi, P. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.05.011 · Cited by 15
Self-citationCost of illness of Primary Biliary Cholangitis - a population-based study
Gerussi, A., Restelli, U., Croce, D., Bonfanti, M., Invernizzi, P., & Carbone, M. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.07.029 · Cited by 14
Self-citationYang, Y., Zhao, R. C., & Zhang, F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.933565 · Cited by 13
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study
Lin, C.-Y., Cheng, Y., Chang, M., & Chien, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-44081-x · Cited by 13
Primary biliary cholangitis in pregnancy: A systematic review with meta-analysis
Jamaly, H. E., Eslick, G. D., & Weltman, M. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.03.005 · Cited by 15
Faisal, M. S., González, H. C., & Gordon, S. C. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.06.005 · Cited by 16
Wang, W., Lian, H., Liang, Y., Ye, Y., Tam, P. K. H., & Chen, Y. (2024) · Cells · doi:10.3390/cells13231997 · Cited by 13
“…by gender, which may be due to differences in the immune system, hormone levels, and environmental and lifestyle factors between males and females [12,13]; for example, it has been reported that the proportion of men who drink alcohol is indeed higher than that of women in the United States [8].”
Hai, L., Wu, J., Pan, X., Yin, W., & Wu, Z. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70084 · Cited by 11
“Traditionally viewed as a biliary disease predominantly affecting women, recent data suggest that the gender ratio may be lower than previously reported, with unexpectedly high mortality rates among male patients [5].”
Madir, A., Božin, T., Mikolašević, I., Milić, S., Štimac, D., Mijić, M., Kanižaj, T. F., Biloglav, Z., Lucijanić, M., Lucijanić, I., et al. (2019) · Croatian Medical Journal · doi:10.3325/cmj.2019.60.494 · Cited by 12
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases
Durazzo, M., Ferro, A., Navarro‐Tableros, V., Gaido, A., Fornengo, P., Altruda, F., Romagnoli, R., Moestrup, S. K., Calvo, P. L., & Fagoonee, S. (2025) · Biomolecules · doi:10.3390/biom15010121 · Cited by 11
“F:M 10:1) [23].”
Cheng, J., Chen, W., Ku, H., Chien, R., & Chang, M. (2023) · Hepatology Research · doi:10.1111/hepr.13910 · Cited by 10
“3:1).(18) In the current study, the female‐ to‐male ratio of PBC was 4.”
BackgroundWatt, M., Hyde, A. M., Spence, J. C., Wright, G. M., Well, S. V., Johnson, E., Mason, A. L., McLeod, M., & Tandon, P. (2023) · Canadian Liver Journal · doi:10.3138/canlivj-2022-0045 · Cited by 9
Risk Stratification in Primary Biliary Cholangitis
Martini, F., Balducci, D., Mancinelli, M., Buzzanca, V., Fracchia, E., Tarantino, G., Benedetti, A., Marzioni, M., & Maroni, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175713 · Cited by 13
Management of Autoimmune Liver Diseases after Liver Transplantation
Barba, R., Medina‐Morales, E., Goyes, D., Patwardhan, V. R., & Bonder, A. (2021) · Transplantology · doi:10.3390/transplantology2020016 · Cited by 10
“Despite that PBC is less frequent in men, the course of the disease is poorer than in women, with higher transplant and mortality rates [41].”
BackgroundImplications of gut microbiota in autoimmune liver diseases
Qian, Q., He, W., Tang, R., & Ma, X. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02860-9 · Cited by 11
Kim, K., Choi, H. Y., Ki, M., Jang, E. S., & Jeong, S. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-01999-4 · Cited by 12
“The female-to-male ratio of PBC incidence and prevalence generally decreased over time [3, 5, 17].”
BackgroundCorpechot, C., Hornus, P., Cals, M., Rinder, P., Marcille, T., Malek, A., Belkacem, K. B., Gaouar, F., Chabane, Y., Corret, P., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101546 · Cited by 11
Liang, M., Ye, S., Jing, R., Zhu, B., Yuan, W., Chu, X., Li, Y., & Zhang, W. (2023) · Environmental Toxicology · doi:10.1002/tox.23906 · Cited by 7
Mortality in Autoimmune Liver Disease in Sweden: A Population‐Based Cohort Study of 9,654 Patients
Lasyte, I., Widman, L., Bergquist, A. M., & Hagström, H. (2025) · Liver International · doi:10.1111/liv.70007 · Cited by 7
“Contrary to some other studies, we did not find male gender to be an inherent determinant for poorer prognosis in PBC [28–30].”
Disparities in Health Care in Patients With Chronic Liver Disease
Zafer, M., Tang, R., Martínez, M. E., Loomba, R., & Tincopa, M. A. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002169 · Cited by 7
Eruzun, H., Bossen, L., Gökçe, D. T., Ergenç, İ., Harput, Z. N., Aydemir, N. G., Akdoğan, M., Yapıcı, H. B., Doğan, T., Holland‐Fischer, P., et al. (2025) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2025.24300 · Cited by 9
Ali, J. S., Ali, T. S., & Hasibuzzaman, M. A. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002868 · Cited by 9
“However, male patients have higher mortality than female patients [ 2 , 3 ] .”
Daza, J., Montagut, N. E., Kautz, A., Langenbacher, D., Hetjens, M., Siegel, F. P., Ebert, M. P., & Teufel, A. (2025) · Digestive Diseases · doi:10.1159/000543229 · Cited by 9
Metadata
- Authors
- Lleo, A., Jepsen, P., Morenghi, E., Carbone, M., Moroni, L., Battezzati, P. M., Podda, M., Mackay, I. R., Gershwin, M. E., & Invernizzi, P.
- Affiliations
- Aarhus University Hospital (DK)
- Humanitas University (IT)
- University of Milan (IT)
- Monash University (AU)
- University of California, Davis (US)
- Corresponding author
- Gershwin, M. Eric
- Invernizzi, Pietro
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-19
- Volume
- 6
- Issue
- 1
- Pages
- 25906-25906
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4872151
- OpenAlex
- W2406168974
- Semantic Scholar
- 9001269fdc4d993a0ebe15ab73b40c226bf70629
- Cited by
- 186
- References
- 62
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 17 · 2023: 29 · 2022: 17 · 2021: 18 · 2020: 15 · 2019: 16 · 2018: 19 · 2017: 17 · 2016: 1
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, sex ratio, incidence, prevalence, all-cause mortality, male mortality, sex differences, population-based registry, Lombardy, Denmark, cholestatic liver disease
- MeSH terms
- Denmark, Female, Humans, Italy, Liver Cirrhosis, Biliary, Male, Registries, Regression Analysis, Sex Characteristics, Incidence, Prevalence, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.